KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Change in Receivables (2016 - 2025)

Teladoc Health (TDOC) has disclosed Change in Receivables for 12 consecutive years, with -$17.5 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 531.16% to -$17.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$25.1 million through Dec 2025, down 6800.27% year-over-year, with the annual reading at -$25.1 million for FY2025, 6800.27% down from the prior year.
  • Change in Receivables hit -$17.5 million in Q4 2025 for Teladoc Health, down from -$16.2 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $27.8 million in Q1 2022 to a low of -$17.5 million in Q4 2025.
  • Historically, Change in Receivables has averaged $2.3 million across 5 years, with a median of $3.3 million in 2021.
  • Biggest five-year swings in Change in Receivables: crashed 580.36% in 2023 and later surged 815.89% in 2025.
  • Year by year, Change in Receivables stood at -$8.2 million in 2021, then soared by 146.04% to $3.8 million in 2022, then surged by 152.07% to $9.6 million in 2023, then crashed by 57.62% to $4.0 million in 2024, then plummeted by 531.16% to -$17.5 million in 2025.
  • Business Quant data shows Change in Receivables for TDOC at -$17.5 million in Q4 2025, -$16.2 million in Q3 2025, and -$6.8 million in Q2 2025.